Cortical circuit dysfunction and cognitive deficits in schizophrenia - implications for preemptive interventions

European Journal of Neuroscience

Volumn 35, Issue 12, 2012, Pages 1871-1878

  Lewis, David A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Gamma oscillations; Humans; Parvalbumin neurons; Prefrontal cortex; Pyramidal neurons; Working memory

Indexed keywords

4 AMINOBUTYRIC ACID CARRIER; ESTROGEN; GLUTAMATE DECARBOXYLASE 67; MESSENGER RNA; PARVALBUMIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ARTICLE; ATTENTION DISTURBANCE; BRAIN CORTEX; BRAIN DYSFUNCTION; CLINICAL FEATURE; COGNITIVE DEFECT; COGNITIVE THERAPY; COMPUTER ASSISTED THERAPY; DRUG EFFECT; ENVIRONMENTAL FACTOR; FLUENCY DISORDER; GABAERGIC TRANSMISSION; GENETIC RISK; HIGH RISK POPULATION; HUMAN; MENTAL PERFORMANCE; NERVE CELL NETWORK; NONHUMAN; PARANOID SCHIZOPHRENIA; PERCEPTION DISORDER; PREFRONTAL CORTEX; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOSIS; RISK FACTOR; SCHIZOPHRENIA; THOUGHT DISORDER; WORKING MEMORY;

ADOLESCENT; ANIMALS; CHILD; COGNITION DISORDERS; EARLY MEDICAL INTERVENTION; HUMANS; INTERNEURONS; PREFRONTAL CORTEX; RATS; SCHIZOPHRENIA;

EID: 84862703272     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2012.08156.x     Document Type: Article

References (112)

1. Akbarian, S., Kim, J.J., Potkin, S.G., Hagman, J.O., Tafazzoli, A., Bunney, W.E. Jr & Jones, E.G. (1995) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry, 52, 258-266.
2. Alexander, G.E. (1982) Functional development of frontal association cortex in monkeys: behavioural and electrophysiological studies. Neurosci. Res. Program Bull., 20, 471-479.
3. Alexander, G.E. & Goldman, P.S. (1978) Functional development of the dorsolateral prefrontal cortex: an analysis utilizing reversible cryogenic depression. Brain Res., 143, 233-249.
4. Anderson, S.A., Classey, J.D., Condé, F., Lund, J.S. & Lewis, D.A. (1995) Synchronous development of pyramidal neuron dendritic spines and parvalbumin-immunoreactive chandelier neuron axon terminals in layer III of monkey prefrontal cortex. Neuroscience, 67, 7-22.
5. Arnold, S.E., Franz, B.R., Gur, R.C., Gur, R.E., Shapiro, R.M., Moberg, P.J. & Trojanowski, J.Q. (1995) Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am. J. Psychiatry, 152, 738-748.
6. Arnsten, A.F., Paspalas, C.D., Gamo, N.J., Yang, Y. & Wang, M. (2010) Dynamic network connectivity: a new form of neuroplasticity. Trends Cogn. Sci., 14, 365-375.
7. Barch, D.M. & Smith, E. (2008) The cognitive neuroscience of working memory: relevance to CNTRICS and schizophrenia. Biol. Psychiatry, 64, 11-17.
8. Beneyto, M., Abbott, A., Hashimoto, T. & Lewis, D.A. (2011) Lamina-specific alterations in cortical GABAA receptor subunit expression in schizophrenia. Cereb. Cortex, 21, 999-1011.
9. Borgwardt, S.J., Riecher-Rossler, A., Dazzan, P., Chitnis, X., Aston, J., Drewe, M., Gschwandtner, U., Haller, S., Pfluger, M., Rechsteiner, E., D'Souza, M., Stieglitz, R.D., Radu, E.W. & McGuire, P.K. (2007) Regional gray matter volume abnormalities in the at risk mental state. Biol. Psychiatry, 61, 1148-1156.
10. Bourgeois, J.-P., Goldman-Rakic, P.S. & Rakic, P. (1994) Synaptogenesis in the prefrontal cortex of rhesus monkeys. Cereb. Cortex, 4, 78-96.
11. Buchanan, R.W., Keefe, R.S., Lieberman, J.A., Barch, D.M., Csernansky, J.G., Goff, D.C., Gold, J.M., Green, M.F., Jarskog, L.F., Javitt, D.C., Kimhy, D., Kraus, M.S., McEvoy, J.P., Mesholam-Gately, R.I., Seidman, L.J., Ball, M.P., McMahon, R.P., Kern, R.S., Robinson, J. & Marder, S.R. (2011) A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biol. Psychiatry, 69, 442-449.
12. Buckley, P.F., Miller, B.J., Lehrer, D.S. & Castle, D.J. (2009) Psychiatric comorbidities and schizophrenia. Schizophr. Bull., 35, 383-402.
13. Buffalo, E.A., Fries, P., Landman, R., Buschman, T.J. & Desimone, R. (2011) Laminar differences in gamma and alpha coherence in the ventral stream. Proc. Natl. Acad. Sci. USA, 108, 11262-11267.
14. Cannon, M., Jones, P.B. & Murray, R.M. (2002) Obstetric complications and schizophrenia: historical and meta-analytic review. Am. J. Psychiatry, 159, 1080-1092.
15. Cannon, T.D., Cadenhead, K., Cornblatt, B., Woods, S.W., Addington, J., Walker, E., Seidman, L.J., Perkins, D., Tsuang, M., McGlashan, T. & Heinssen, R. (2008) Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch. Gen. Psychiatry, 65, 28-37.
16. Cardin, J.A., Carlen, M., Meletis, K., Knoblich, U., Zhang, F., Deisseroth, K., Tsai, L.H. & Moore, C.I. (2009) Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature, 459, 663-667.
17. Cardno, A.G., Marshall, E.J., Coid, B., MacDonald, A.M., Ribchester, T.R., Davies, N.J., Venturi, P., Jones, L.A., Lewis, S.W., Sham, P.C., Gottesman, I.I., Farmer, A.E., McGuffin, P., Reveley, A.M. & Murray, R.M. (1999) Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch. Gen. Psychiatry, 56, 162-168.
18. Castner, S.A., Arriza, J.L., Roberts, J.C., Mrzljak, L., Christian, E.P. & Williams, G.V. (2010) Reversal of ketamine-induced working memory impairments by the GABAAalpha2/3 agonist TPA023. Biol. Psychiatry, 67, 998-1001.
19. Chien, I.C., Hsu, J.H., Lin, C.H., Bih, S.H., Chou, Y.J. & Chou, P. (2009) Prevalence of diabetes in patients with schizophrenia in Taiwan: a population-based National Health Insurance study. Schizophr. Res., 111, 17-22.
20. Cho, R.Y., Konecky, R.O. & Carter, C.S. (2006) Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. Proc. Natl. Acad. Sci. USA, 103, 19878-19883.
21. Cosway, R., Byrne, M., Clafferty, R., Hodges, A., Grant, E., Abukmeil, S.S., Lawrie, S.M., Miller, P. & Johnstone, E.C. (2000) Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study. Psychol. Med., 30, 1111-1121.
22. Cruz, D.A., Eggan, S.M. & Lewis, D.A. (2003) Postnatal development of pre- and post-synaptic GABA markers at chandelier cell inputs to pyramidal neurons in monkey prefrontal cortex. J. Comp. Neurol., 465, 385-400.
23. Cruz, D.A., Weaver, C.L., Lovallo, E.M., Melchitzky, D.S. & Lewis, D.A. (2009) Selective alterations in postsynaptic markers of chandelier cell inputs to cortical pyramidal neurons in subjects with schizophrenia. Neuropsychopharmacology, 34, 2112-2124.
24. Curley, A.A., Arion, D., Volk, D.W., Asafu-Adjei, J.K., Sampson, A.R., Fish, K.N. & Lewis, D.A. (2011) Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features. Am. J. Psychiatry, 168, 921-929.
25. Davidson, M., Reichenberg, A., Rabinowitz, J., Weiser, M., Kaplan, Z. & Mark, M. (1999) Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am. J. Psychiatry, 156, 1328-1335.
26. Deserno, L., Sterzer, P., Wustenberg, T., Heinz, A. & Schlagenhauf, F. (2012) Reduced prefrontal-parietal effective connectivity and working memory deficits in schizophrenia. J. Neurosci., 32, 12-20.
27. Dixon, L. (1999) Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr. Res., 35(Suppl.), S93-S100.
28. Dumitriu, D., Hao, J., Hara, Y., Kaufmann, J., Janssen, W.G., Lou, W., Rapp, P.R. & Morrison, J.H. (2010) Selective changes in thin spine density and morphology in monkey prefrontal cortex correlate with aging-related cognitive impairment. J. Neurosci., 30, 7507-7515.
29. Eack, S.M., Hogarty, G.E., Cho, R.Y., Prasad, K.M., Greenwald, D.P., Hogarty, S.S. & Keshavan, M.S. (2010) Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Arch. Gen. Psychiatry, 67, 674-682.
30. Egan, M.F., Goldberg, T.E., Gscheidle, T., Weirich, M., Rawlings, R., Hyde, T.M., Bigelow, L. & Weinberger, D.R. (2001) Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biol. Psychiatry, 50, 98-107.
31. Erickson, S.L. & Lewis, D.A. (2002) Postnatal development of parvalbumin- and GABA transporter-immunoreactive axon terminals in monkey prefrontal cortex. J. Comp. Neurol., 448, 186-202.
32. Feinberg, I. (1982) Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J. Psychiatry Res., 17, 319-334.
33. Garey, L.J., Ong, W.Y., Patel, T.S., Kanani, M., Davis, A., Mortimer, A.M., Barnes, T.R.E. & Hirsch, S.R. (1998) Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J. Neurol. Neurosurg. Psychiatry, 65, 446-453.
34. Geddes, J.R. & Lawrie, S.M. (1995) Obstetric complications and schizophrenia: a meta-analysis. Br. J. Psychiatry, 167, 786-793.
35. Gee, D.G., Karlsgodt, K.H., Van Erp, T.G., Bearden, C.E., Lieberman, M.D., Belger, A., Perkins, D.O., Olvet, D.M., Cornblatt, B.A., Constable, T., Woods, S.W., Addington, J., Cadenhead, K.S., McGlashan, T.H., Seidman, L.J., Tsuang, M.T., Walker, E.F. & Cannon, T.D. (2012) Altered age-related trajectories of amygdala-prefrontal circuitry in adolescents at clinical high risk for psychosis: a preliminary study. Schizophr. Res., 134, 1-9.
36. Giedd, J.N. & Rapoport, J.L. (2010) Structural MRI of pediatric brain development: what have we learned and where are we going? Neuron, 67, 728-734.
37. Glantz, L.A. & Lewis, D.A. (1997) Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia: regional and diagnostic specificity. Arch. Gen. Psychiatry, 54, 943-952.
38. Glantz, L.A. & Lewis, D.A. (2000) Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry, 57, 65-73.
39. Glausier, J.R. & Lewis, D.A. (2011) Selective pyramidal cell reduction of GABA(A) receptor alpha1 subunit messenger RNA expression in schizophrenia. Neuropsychopharmacology, 36, 2103-2110.
40. Goldman-Rakic, P.S. (1987) Development of cortical circuitry and cognitive function. Child Dev., 58, 601-622.
41. Goldman-Rakic, P.S. (1995) Cellular basis of working memory. Neuron, 14, 477-485.
42. Gonzalez-Burgos, G. & Lewis, D.A. (2008) GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr. Bull., 34, 944-961.
43. Gonzalez-Burgos, G., Kroener, S., Zaitsev, A.V., Povysheva, N.V., Krimer, L.S., Barrionuevo, G. & Lewis, D.A. (2008) Functional maturation of excitatory synapses in layer 3 pyramidal neurons during postnatal development of the primate prefrontal cortex. Cereb. Cortex, 18, 626-637.
44. Gonzalez-Burgos, G., Hashimoto, T. & Lewis, D.A. (2010) Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr. Psychiatry Rep., 12, 335-344.
45. Gottesman, I.I. (1991) Schizophrenia Genesis: The Origins of Madness. W.H. Freeman, New York.
46. Grant, P.M., Huh, G.A., Perivoliotis, D., Stolar, N.M. & Beck, A.T. (2012) Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia. Arch. Gen. Psychiatry, 69, 121-127.
47. Green, M.F. (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am. J. Psychiatry, 153, 321-330.
48. Hao, J., Rapp, P.R., Janssen, W.G., Lou, W., Lasley, B.L., Hof, P.R. & Morrison, J.H. (2007) Interactive effects of age and estrogen on cognition and pyramidal neurons in monkey prefrontal cortex. Proc. Natl. Acad. Sci. USA, 104, 11465-11470.
49. Hashimoto, T., Volk, D.W., Eggan, S.M., Mirnics, K., Pierri, J.N., Sun, Z., Sampson, A.R. & Lewis, D.A. (2003) Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J. Neurosci., 23, 6315-6326.
50. Haukka, J., Suvisaari, J. & Lonnqvist, J. (2003) Fertility of patients with schizophrenia, their siblings, and the general population: a cohort study from 1950 to 1959 in Finland. Am. J. Psychiatry, 160, 460-463.
51. Hill, J.J., Hashimoto, T. & Lewis, D.A. (2006) Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia. Mol. Psychiatry, 11, 557-566.
52. Hoffman, R.E. & Dobscha, S.K. (1989) Cortical pruning and the development of schizophrenia: a computer model. Schizophr. Bull., 15, 477-490.
53. Hoftman, G.D. & Lewis, D.A. (2011) Postnatal developmental trajectories of neural circuits in the primate prefrontal cortex: identifying sensitive periods for vulnerability to schizophrenia. Schizophr. Bull., 37, 493-503.
54. Huttenlocher, P.R. & Dabholkar, A.S. (1997) Regional differences in synaptogenesis in human cerebral cortex. J. Comp. Neurol., 387, 167-178.
55. Ide, M. & Lewis, D.A. (2010) Altered cortical CDC42 signaling pathways in schizophrenia: implications for dendritic spine deficits. Biol. Psychiatry, 68, 25-32.
56. Insel, T.R. (2010) Rethinking schizophrenia. Nature, 468, 187-193.
57. Johnston, L.D., O'Malley, P.M., Bachman, J.G. & Schulenberg, J.E. (2012) Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2011. Institute for Social Research, The University of Michigan, Ann Arbor, MI.
58. Kasai, H., Matsuzaki, M., Noguchi, J., Yasumatsu, N. & Nakahara, H. (2003) Structure-stability-function relationships of dendritic spines. Trends Neurosci., 26, 360-368.
59. Keefe, R.S. & Fenton, W.S. (2007) How should DSM-V criteria for schizophrenia include cognitive impairment? Schizophr. Bull., 33, 912-920.
60. Khashan, A.S., Abel, K.M., McNamee, R., Pedersen, M.G., Webb, R.T., Baker, P.N., Kenny, L.C. & Mortensen, P.B. (2008) Higher risk of offspring schizophrenia following antenatal maternal exposure to severe adverse life events. Arch. Gen. Psychiatry, 65, 146-152.
61. Kim, Y., Zerwas, S., Trace, S.E. & Sullivan, P.F. (2011) Schizophrenia genetics: where next? Schizophr. Bull., 37, 456-463.
62. Kolluri, N., Sun, Z., Sampson, A.R. & Lewis, D.A. (2005) Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. Am. J. Psychiatry, 162, 1200-1202.
63. Kulkarni, J., Gurvich, C., Lee, S.J., Gilbert, H., Gavrilidis, E., de Castella, A., Berk, M., Dodd, S., Fitzgerald, P.B. & Davis, S.R. (2010) Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia. Psychoneuroendocrinology, 35, 1142-1147.
64. Lawrie, S.M. & Abukmeil, S.S. (1998) Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br. J. Psychiatry, 172, 110-120.
65. Lesh, T.A., Niendam, T.A., Minzenberg, M.J. & Carter, C.S. (2011) Cognitive control deficits in schizophrenia: mechanisms and meaning. Neuropsychopharmacology, 36, 316-338.
66. Levitt, J.J., Bobrow, L., Lucia, D. & Srinivasan, P. (2010) A selective review of volumetric and morphometric imaging in schizophrenia. Curr. Top. Behav. Neurosci., 4, 243-281.
67. Lewis, D.A. (2011) Pharmacological enhancement of cognition in individuals with schizophrenia. Biol. Psychiatry, 69, 397-398.
68. Lewis, D.A. & Gonzalez-Burgos, G. (2008) Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology, 33, 141-165.
69. Lewis, D.A. & Levitt, P. (2002) Schizophrenia as a disorder of neurodevelopment. Annu. Rev. Neurosci., 25, 409-432.
70. Lewis, D.A. & Sweet, R.A. (2009) Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies. J. Clin. Invest., 119, 706-716.
71. Lewis, D.A., Hashimoto, T. & Volk, D.W. (2005) Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci., 6, 312-324.
72. Lewis, D.A., Cho, R.Y., Carter, C.S., Eklund, K., Forster, S., Kelly, M.A. & Montrose, D. (2008) Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia. Am. J. Psychiatry, 165, 1585-1593.
73. Lewis, D.A., Curley, A.A., Glausier, J.R. & Volk, D.W. (2012) Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci., 35, 57-67.
74. Lopez, A.D., Mathers, C.D., Ezzati, M., Jamison, D.T. & Murray, C.J.L. (Eds) (2006) Global Burden of Disease. The World Bank/Oxford University Press, Washington, DC/New York, NY.
75. Luna, B., Padmanabhan, A. & O'Hearn, K. (2010) What has fMRI told us about the development of cognitive control through adolescence? Brain Cogn., 72, 101-113.
76. McIntosh, A.M., Owens, D.C., Moorhead, W.J., Whalley, H.C., Stanfield, A.C., Hall, J., Johnstone, E.C. & Lawrie, S.M. (2011) Longitudinal volume reductions in people at high genetic risk of schizophrenia as they develop psychosis. Biol. Psychiatry, 69, 953-958.
77. Mechelli, A., Riecher-Rossler, A., Meisenzahl, E.M., Tognin, S., Wood, S.J., Borgwardt, S.J., Koutsouleris, N., Yung, A.R., Stone, J.M., Phillips, L.J., McGorry, P.D., Valli, I., Velakoulis, D., Woolley, J., Pantelis, C. & McGuire, P. (2011) Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study. Arch. Gen. Psychiatry, 68, 489-495.
78. Mednick, S.A., Machon, R.A. & Huttunen, M. (1989). Disturbances of fetal neural development and adult schizophrenia. In Schultz, S.C. & Tamminga, C.A. (Eds), Schizophrenia: Scientific Progress. Oxford University Press, New York, pp. 69-77.
79. Miller, E.K. & Cohen, J.D. (2001) An integrative theory of prefrontal cortex function. Annu. Rev. Neurosci., 24, 167-202.
80. Minzenberg, M.J., Firl, A.J., Yoon, J.H., Gomes, G.C., Reinking, C. & Carter, C.S. (2010) Gamma oscillatory power is impaired during cognitive control independent of medication status in first-episode schizophrenia. Neuropsychopharmacology, 35, 2590-2599.
81. Moore, T.H., Zammit, S., Lingford-Hughes, A., Barnes, T.R., Jones, P.B., Burke, M. & Lewis, G. (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet, 370, 319-328.
82. Morgan, C., Charalambides, M., Hutchinson, G. & Murray, R.M. (2010) Migration, ethnicity, and psychosis: toward a sociodevelopmental model. Schizophr. Bull., 36, 655-664.
83. van Os, J., Kenis, G. & Rutten, B.P. (2010) The environment and schizophrenia. Nature, 468, 203-212.
84. Osborn, D.P., Levy, G., Nazareth, I., Petersen, I., Islam, A. & King, M.B. (2007) Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database. Arch. Gen. Psychiatry, 64, 242-249.
85. Palmer, B.A., Pankratz, V.S. & Bostwick, J.M. (2005) The lifetime risk of suicide in schizophrenia: a reexamination. Arch. Gen. Psychiatry, 62, 247-253.
86. Pantelis, C., Velakoulis, D., McGorry, P.D., Wood, S.J., Suckling, J., Phillips, L.J., Yung, A.R., Bullmore, E.T., Brewer, W., Soulsby, B., Desmond, P. & McGuire, P.K. (2003) Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet, 361, 281-288.
87. Pedersen, C.B. & Mortensen, P.B. (2001) Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk. Arch. Gen. Psychiatry, 58, 1039-1046.
88. Petanjek, Z., Judas, M., Simic, G., Rasin, M.R., Uylings, H.B., Rakic, P. & Kostovic, I. (2011) Extraordinary neoteny of synaptic spines in the human prefrontal cortex. Proc. Natl. Acad. Sci. USA, 108, 13281-13286.
89. Pierri, J.N., Volk, C.L.E., Auh, S., Sampson, A. & Lewis, D.A. (2001) Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. Arch. Gen. Psychiatry, 58, 466-473.
90. Rajkowska, G., Selemon, L.D. & Goldman-Rakic, P.S. (1998) Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch. Gen. Psychiatry, 55, 215-224.
91. Reichenberg, A., Caspi, A., Harrington, H., Houts, R., Keefe, R.S., Murray, R.M., Poulton, R. & Moffitt, T.E. (2010) Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. Am. J. Psychiatry, 167, 160-169.
92. Saha, S., Chant, D. & McGrath, J. (2007) A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch. Gen. Psychiatry, 64, 1123-1131.
93. Seidman, L.J., Giuliano, A.J., Meyer, E.C., Addington, J., Cadenhead, K.S., Cannon, T.D., McGlashan, T.H., Perkins, D.O., Tsuang, M.T., Walker, E.F., Woods, S.W., Bearden, C.E., Christensen, B.K., Hawkins, K., Heaton, R., Keefe, R.S., Heinssen, R. & Cornblatt, B.A. (2010) Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch. Gen. Psychiatry, 67, 578-588.
94. Selemon, L.D. & Goldman-Rakic, P.S. (1999) The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry, 45, 17-25.
95. Shaikh, M., Valmaggia, L., Broome, M.R., Dutt, A., Lappin, J., Day, F., Woolley, J., Tabraham, P., Walshe, M., Johns, L., Fusar-Poli, P., Howes, O., Murray, R.M., McGuire, P. & Bramon, E. (2012) Reduced mismatch negativity predates the onset of psychosis. Schizophr. Res., 134, 42-48.
96. Sohal, V.S., Zhang, F., Yizhar, O. & Deisseroth, K. (2009) Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature, 459, 698-702.
97. Stan, A. & Lewis, D.A. (2012) Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies. Curr. Pharm. Biotechnol., Epub ahead of print.
98. Steen, R.G., Mull, C., McClure, R., Hamer, R.M. & Lieberman, J.A. (2006) Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br. J. Psychiatry, 188, 510-518.
99. Subramaniam, K., Luks, T.L., Fisher, M., Simpson, G.V., Nagarajan, S.S. & Vinogradov, S. (2012) Computerized cognitive training restores neural activity within the reality monitoring network in schizophrenia. Neuron, 73, 842-853.
100. Sullivan, P.F. (2008) Schizophrenia genetics: the search for a hard lead. Curr. Opin. Psychiatry, 21, 157-160.
101. Sun, D., Phillips, L., Velakoulis, D., Yung, A., McGorry, P.D., Wood, S.J., Van Erp, T.G., Thompson, P.M., Toga, A.W., Cannon, T.D. & Pantelis, C. (2009) Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr. Res., 108, 85-92.
102. Susser, E., Neugebauer, R., Hoek, H.W., Brown, A.S., Lin, S., Labovitz, D. & Gorman, J.M. (1996) Schizophrenia after prenatal famine: further evidence. Arch. Gen. Psychiatry, 53, 25-31.
103. Sweet, R.A., Pierri, J.N., Auh, S., Sampson, A.R. & Lewis, D.A. (2003) Reduced pyramidal cell somal volume in auditory association cortex of subjects with schizophrenia. Neuropsychopharmacology, 28, 599-609.
104. Sweet, R.A., Bergen, S.E., Sun, Z., Sampson, A.R., Pierri, J.N. & Lewis, D.A. (2004) Pyramidal cell size reduction in schizophrenia: evidence for involvement of auditory feedforward circuits. Biol. Psychiatry, 55, 1128-1137.
105. Tang, Y., Janssen, W.G., Hao, J., Roberts, J.A., McKay, H., Lasley, B., Allen, P.B., Greengard, P., Rapp, P.R., Kordower, J.H., Hof, P.R. & Morrison, J.H. (2004) Estrogen replacement increases spinophilin-immunoreactive spine number in the prefrontal cortex of female rhesus monkeys. Cereb. Cortex, 14, 215-223.
106. Thune, J.J., Uylings, H.B.M. & Pakkenberg, B. (2001) No deficit in total number of neurons in the prefrontal cortex in schizophrenics. J. Psychiatr. Res., 35, 15-21.
107. Usall, J., Huerta-Ramos, E., Iniesta, R., Cobo, J., Araya, S., Roca, M., Serrano-Blanco, A., Teba, F. & Ochoa, S. (2011) Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial. J. Clin. Psychiatry, 72, 1552-1557.
108. Van Snellenberg, J.X., Torres, I.J. & Thornton, A.E. (2006) Functional neuroimaging of working memory in schizophrenia: task performance as a moderating variable. Neuropsychology, 20, 497-510.
109. Volk, D.W., Pierri, J.N., Fritschy, J.-M., Auh, S., Sampson, A.R. & Lewis, D.A. (2002) Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb. Cortex, 12, 1063-1070.
110. Woo, T.-U., Whitehead, R.E., Melchitzky, D.S. & Lewis, D.A. (1998) A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc. Natl. Acad. Sci. USA, 95, 5341-5346.
111. Woodruff, A.R., McGarry, L.M., Vogels, T.P., Inan, M., Anderson, S.A. & Yuste, R. (2011) State-dependent function of neocortical chandelier cells. J. Neurosci., 31, 17872-17886.
112. Ziermans, T.B., Schothorst, P.F., Sprong, M., Magnee, M.J., van Engeland, H. & Kemner, C. (2012) Reduced prepulse inhibition as an early vulnerability marker of the psychosis prodrome in adolescence. Schizophr. Res., 134, 10-15.